The Top Analysis for Gilead Sciences Inc (GILD)


The top analysis was written by Noah Brody titled Which is the Better Buy? Gilead Sciences vs Bristol-Myers Squibb

Is Gilead Sciences Inc (GILD) a buy?

Based on 3 suggestions, Gilead Sciences Inc(GILD) is recommended as a BUY

Are These Ratings Good?

Based on 3 ratings, the average Return is 37.91%.
The community has successfully rated this stock!

Forecast for Gilead Sciences Inc (GILD)

Based on the most recent price of $101.78,
the two year forecast for GILD is $115.51.
The four year forecast is $129.25
Forecast is based on the aggregate sentiment of users on the platform. The sentiment of top investors get a higher ranking when assessing the forecast.